Hot Features
Quoin Pharmaceuticals, Ltd., a late-stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases in the United States. The company’s lead product is QRX003, a topical lotion, which is in phase 2 to treat netherton syndr... Quoin Pharmaceuticals, Ltd., a late-stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases in the United States. The company’s lead product is QRX003, a topical lotion, which is in phase 2 to treat netherton syndrome (NS); phase 1 in to treat peeling skin syndrome; and in pre-clinical stage to treat SAM syndrome and ichthyosis. It also develops QRX008 for the treatment of scleroderma, which is in pre-clinical stage; and QRX009, to treat microcystic lymphatic malformations, venous malformations, angiofibroma, and other diseases. It has a research agreement with Queensland University of Technology. Quoin Pharmaceuticals, Ltd. was founded in 2018 and is based in Ashburn, Virginia. Quoin Pharmaceuticals, Ltd. is a subsidiary of Skinvisible, Inc. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.31 | -6.87361419069 | 4.51 | 5.15 | 4.21 | 23493 | 4.72125051 | DR |
| 4 | -1.55 | -26.9565217391 | 5.75 | 5.8215 | 4.11 | 34165 | 4.82050403 | DR |
| 12 | -3.93 | -48.3394833948 | 8.13 | 10.06 | 4.11 | 99838 | 8.1288476 | DR |
| 26 | -7.09 | -62.7989371125 | 11.29 | 14.9 | 4.11 | 63591 | 8.77529863 | DR |
| 52 | -4.11 | -49.4584837545 | 8.31 | 41.8 | 4.11 | 194424 | 13.79002842 | DR |
| 156 | 3.7236 | 781.61209068 | 0.4764 | 41.8 | 0.1664 | 1128260 | 1.50853403 | DR |
| 260 | -8.7 | -67.4418604651 | 12.9 | 41.8 | 0.1664 | 1215895 | 2.18753961 | DR |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.